Latest total assets for AMBS: $10M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Amarantus BioScience Holdings (AMBS) currently reports a total assets of $10M as of March 2023. That compares with $12M in the prior-year period — down 12.7% year over year. Use the charts on this page to explore Amarantus BioScience Holdings's total assets history and peer comparisons.
Amarantus BioScience Holdings's total assets decreased from $12M to $10M — a 12.7% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Amarantus BioScience Holdings reported $10M in total assets as of March 2023. That compares with $12M in the prior-year period — down 12.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Amarantus BioScience Holdings, and consider following AMBS for alerts when major investors trade the stock.
Amarantus BioScience Holdings is classified in the Healthcare sector. On total assets, it currently shows $10M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMBS with unrelated industries.